Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	35.55	35.33	26.06
Graham Fair Price	-16.83	6.70	8.05
PEG	-55.26	-0.31	0.70
Price/Book	2.72	2.03	1.98
Price/Cash Flow	0.73	-14.62	14.52
Prices/Earnings	53.48	9.99	6.51
Price/Sales	40.82	3.33	2.36
Price/FCF	0.73	-14.62	14.52
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	9.94	0.34	0.31
Operating Margin	4.49	0.21	0.20
ROA	-34.01	< 0.005	0.01
ROE	0.08	0.05	-33.07
ROIC	0.03	0.02	-34.22
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.02	0.11	-84.02
Dividends QOQ	2.54	-0.85	-66.51
EBIT QOQ	2.37	-0.26	-89.08
EPS QOQ	0.09	-0.32	243.09
FCF QOQ	13.01	-1.99	-84.69
Revenue QOQ	0.13	-0.29	115.74
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	106.07	174.56	64.57
Days Sales Outstanding (DSO)	328.12	457.66	39.48
Inventory Turnover	0.85	0.52	-39.24
Debt/Capitalization	0.77	0.78	1.18
Quick Ratio	1.71	5.18	203.37
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	6.16	6.26	1.66
Cash	3.90	3.20	-17.95
Capex	-0.31	-0.16	48.50
Free Cash Flow	0.84	-0.87	3.67
Revenue	5.16	3.82	-25.84
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	2.02	6.30	211.56
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	15.24	21.23	39.34
Naive Interpretation	Member

06 - Financial Health · Bad

Rating